1. Home
  2. CIVB vs CTMX Comparison

CIVB vs CTMX Comparison

Compare CIVB & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CIVB
  • CTMX
  • Stock Information
  • Founded
  • CIVB 1884
  • CTMX 2008
  • Country
  • CIVB United States
  • CTMX United States
  • Employees
  • CIVB N/A
  • CTMX N/A
  • Industry
  • CIVB Major Banks
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CIVB Finance
  • CTMX Health Care
  • Exchange
  • CIVB Nasdaq
  • CTMX Nasdaq
  • Market Cap
  • CIVB 466.9M
  • CTMX 380.9M
  • IPO Year
  • CIVB N/A
  • CTMX 2015
  • Fundamental
  • Price
  • CIVB $20.01
  • CTMX $1.91
  • Analyst Decision
  • CIVB Buy
  • CTMX Strong Buy
  • Analyst Count
  • CIVB 5
  • CTMX 3
  • Target Price
  • CIVB $25.50
  • CTMX $5.67
  • AVG Volume (30 Days)
  • CIVB 106.5K
  • CTMX 3.1M
  • Earning Date
  • CIVB 07-24-2025
  • CTMX 08-07-2025
  • Dividend Yield
  • CIVB 3.40%
  • CTMX N/A
  • EPS Growth
  • CIVB 18.46
  • CTMX 263.20
  • EPS
  • CIVB 2.52
  • CTMX 0.49
  • Revenue
  • CIVB $157,428,000.00
  • CTMX $141,100,000.00
  • Revenue This Year
  • CIVB $17.31
  • CTMX N/A
  • Revenue Next Year
  • CIVB $9.98
  • CTMX N/A
  • P/E Ratio
  • CIVB $7.93
  • CTMX $3.91
  • Revenue Growth
  • CIVB 7.00
  • CTMX 18.01
  • 52 Week Low
  • CIVB $15.85
  • CTMX $0.40
  • 52 Week High
  • CIVB $25.59
  • CTMX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • CIVB 42.29
  • CTMX 39.81
  • Support Level
  • CIVB $19.01
  • CTMX $1.72
  • Resistance Level
  • CIVB $20.98
  • CTMX $2.43
  • Average True Range (ATR)
  • CIVB 0.49
  • CTMX 0.20
  • MACD
  • CIVB 0.16
  • CTMX -0.06
  • Stochastic Oscillator
  • CIVB 52.22
  • CTMX 26.84

About CIVB Civista Bancshares Inc.

Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: